The value of physiologic vitamin D as a biomarker of dementia

Drugs of Today

Volumn 47, Issue 3, 2011, Pages 223-231

  Buell, J S ^a   Tucker, Katherine L ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D; 25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; DRUG DERIVATIVE;

ABSORPTION; ALZHEIMER DISEASE; COGNITION; COMORBIDITY; CONCENTRATION (PARAMETERS); DEMENTIA; HUMAN; METABOLIC ACTIVATION; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NONHUMAN; PREVALENCE; REVIEW; VITAMIN D DEFICIENCY; VITAMIN METABOLISM; BLOOD; PHYSIOLOGY;

BIOLOGICAL MARKERS; COGNITION; DEMENTIA; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 80051925626     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2011.47.3.1517492     Document Type: Review

References (64)

1. National Institute on Aging. Alzheimer's Disease Education and Referral Center. http://www.nia.nih.gov/Alzheimers/AlzheimersInformation/GeneralInfo/. Accessed March 31, 2011.
2. Schneider, J.A., Boyle, P.A., Arvanitakis, Z., Bienias, J.L., Bennett, D.A. Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol 2007, 62(1): 59-66.
3. Geldmacher, D.S., Whitehouse, P.J. Evaluation of dementia. N Engl J Med 1996, 335(5): 330-6.
4. Snowdon, D.A., Greiner, L.H., Mortimer, J.A., Riley, K.P., Greiner, P.A., Markesbery, W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277(10): 813-7.
5. Pendlebury, S.T., Rothwell, P.M. Risk of recurrent stroke, other vascular events and dementia after transient ischaemic attack and stroke. Cerebrovasc Dis 2009, 27(Suppl. 3): 1-11.
6. Atkinson, A.J., Colburn, W.A., DeGruttola, V.G. et al. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69(3): 89-95.
7. Giovannucci, E., Liu, Y., Hollis, B.W., Rimm, E.B. 25- Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168(11): 1174-80.
8. Melamed, M.L., Muntner, P., Michos, E.D., Uribarri, J., Weber, C., Sharma, J., Raggi, P. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol 2008, 28(6): 1179-85.
9. Pfeifer, M., Begerow, B., Minne, H.W., Nachtigall, D., Hansen, C. Effects of a short-term vitamin D3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001, 86(4): 1633-7.
10. Pilz, S., Dobnig, H., Fischer, J.E., Wellnitz, B., Seelhorst, U., Boehm, B.O., Marz, W. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008, 39(9): 2611-3.
11. Wang, L., Manson, J.E., Buring, J.E., Lee, I.M., Sesso, H.D. Dietary intake of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women. Hypertension 2008, 51(4): 1073-9.
12. Buell, J.S., Dawson-Hughes, B., Scott, T.M. et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010, 74(1): 18-26.
13. Wang, Y., Chiang, Y.H., Su, T.P., Hayashi, T., Morales, M., Hoffer, B.J., Lin, S.Z. Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology 2000, 39(5): 873-80.
14. Buell, J.S., Scott, T.M., Dawson-Hughes, B., Dallal, G.E., Rosenberg, I.H., Folstein, M.F., Tucker, K.L. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 2009, 64(8): 888-95.
15. Evatt, M.L., Delong, M.R., Khazai, N., Rosen, A., Triche, S., Tangpricha, V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol 2008, 65(10): 1348-52.
16. Przybelski, R.J., Binkley, N.C. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys 2007, 460(2): 202-5.
17. Wilkins, C.H., Birge, S.J., Sheline, Y.I., Morris, J.C. Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J Natl Med Assoc 2009, 101(4): 349-54.
18. Wilkins, C.H., Sheline, Y.I., Roe, C.M., Birge, S.J., Morris, J.C. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006, 14: 1033-40.
19. Lee, D.M., Tajar, A., Ulubaev, A. et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatry 2009, 80(7): 722-9.
20. Llewellyn, D.J., Lang, I.A., Langa, K.M. et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Intern Med 2010, 170(13): 1135-41.
21. Llewellyn, D.J., Langa, K.M., Lang, I.A. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol 2009, 22(3): 188-95.
22. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34(7): 939-44.
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). American Psychiatric Association: Washington, D.C. 1994.
24. Geldmacher, D.S., Whitehouse, P.J., Jr. Differential diagnosis of Alzheimer's disease. Neurology 1997, 48(5 Suppl. 6): S2-9.
25. Roman, G.C. Stroke, cognitive decline and vascular dementia: the silent epidemic of the 21st century. Neuroepidemiology 2003, 22(3): 161-4.
26. Skoog, I. Vascular aspects in Alzheimer's disease. J Neural Transm Suppl 2000, 59: 37-43.
27. Lopez, O.L., Kuller, L.H., Fitzpatrick, A., Ives, D., Becker, J.T., Beauchamp, N. Evaluation of dementia in the cardiovascular health cognition study. Neuroepidemiology 2003, 22(1): 1-12.
28. Roman, G.C., Tatemichi, T.K., Erkinjuntti, T. et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43(2): 250-60.
29. Goodwin, J., Goodwin, J.M., Garry, P.J. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983, 249(21): 2917-21.
30. Stumpf, W.E., Clark, S.A., O'Brien, L.P., Reid, F.A. 1,25(OH)2 vitamin D3 sites of action in spinal cord and sensory ganglion. Anat Embryol (Berl) 1988, 177(4): 307-10.
31. Balabanova, S., Richter, H.P., Antoniadis, G., Homoki, J., Kremmer, N., Hanle, J., Teller, W.M. 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid. Klin Wochenschr 1984, 62(22): 1086-90.
32. Veenstra, T.D., Prufer, K., Koenigsberger, C., Brimijoin, S.W., Grande, J.P., Kumar, R. 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res 1998, 804(2): 193-205.
33. Taylor, A.N. Chick brain calcium binding protein: response to cholecalciferol and some developmental aspects. J Nutr 1977, 107(3): 480-6.
34. Gascon-Barre, M., Huet, P.M. Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. Am J Physiol 1983, 244(3): E266-71.
35. Clemens, T.L., Garrett, K.P., Zhou, X.Y., Pike, J.W., Haussler, M.R., Dempster, D.W. Immunocytochemical localization of the 1,25-dihydroxyvitamin D3 receptor in target cells. Endocrinology 1988, 122(4): 1224-30.
36. Eyles, D., Brown, J., Mackay-Sim, A., McGrath, J., Feron, F. Vitamin D3 and brain development. Neuroscience 2003, 118(3): 641-53.
37. McGrath, J.J., Feron, F.P., Burne, T.H., Mackay-Sim, A., Eyles, D.W. Vitamin D3-implications for brain development. J Steroid Biochem Mol Biol 2004, 89-90(1-5): 557-60.
38. Garcion, E., Wion-Barbot, N., Montero-Menei, C.N., Berger, F., Wion, D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002, 13(3): 100-5.
39. Langub, M.C., Herman, J.P., Malluche, H.H., Koszewski, N.J. Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience 2001, 104(1): 49-56.
40. Prufer, K., Veenstra, T.D., Jirikowski, G.F., Kumar, R. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat 1999, 16(2): 135-45.
41. Neveu, I., Naveilhan, P., Jehan, F., Baudet, C., Wion, D., De Luca, H.F., Brachet, P. 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res Mol Brain Res 1994, 24(1-4): 70-6.
42. Zehnder, D., Bland, R., Williams, M.C., McNinch, R.W., Howie, A.J., Stewart, P.M., Hewison, M. Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 2001, 86(2): 888-94.
43. Garcion, E., Nataf, S., Berod, A., Darcy, F., Brachet, P. 1,25-Dihydroxyvitamin D3 inhibits the expression of inducible nitric oxide synthase in rat central nervous system during experimental allergic encephalomyelitis. Brain Res Mol Brain Res 1997, 45(2): 255-67.
44. Garcion, E., Sindji, L., Montero-Menei, C., Andre, C., Brachet, P., Darcy, F. Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia 1998, 22(3): 282-94.
45. Annweiler, C., Schott, A.M., Allali, G. et al. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 2010, 74(1): 27-32.
46. Slinin, Y., Paudel, M.L., Taylor, B.C. et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 2010, 74(1): 33-41.
47. Scott, T.M., Peter, I., Tucker, K.L. et al. The Nutrition, Aging, and Memory in Elders (NAME) study: design and methods for a study of micronutrients and cognitive function in a homebound elderly population. Int J Geriatr Psychiatry 2006, 21(6): 519-28.
48. Fleck, A. Latitude and ischaemic heart disease. Lancet 1989, 1(8638): 613.
49. Wong, A. Incident solar radiation and coronary heart disease mortality rates in Europe. Eur J Epidemiol 2008, 23(9): 609-14.
50. Zittermann, A., Schleithoff, S.S., Koerfer, R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94(4): 483-92.
51. Li, Y.C., Kong, J., Wei, M., Chen, Z.F., Liu, S.Q., Cao, L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110(2): 229-38.
52. Li, Y.C., Qiao, G., Uskokovic, M., Xiang, W., Zheng, W., Kong, J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004, 89-90(1-5): 387-92.
53. Krause, R., Buhring, M., Hopfenmuller, W., Holick, M.F., Sharma, A.M. Ultraviolet B and blood pressure. Lancet 1998, 352(9129): 709-10.
54. Scragg, R., Sowers, M., Bell, C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007, 20(7): 713-9.
55. Reis, J.P., Michos, E.D., von Muhlen, D., Miller, E.R., 3rd Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr 2008, 88(6): 1469-77.
56. Zittermann, A., Schleithoff, S.S., Tenderich, G., Berthold, H.K., Korfer, R., Stehle, P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003, 41(1): 105-12.
57. Hypponen, E., Berry, D., Cortina-Borja, M., Power, C. 25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One 2010, 5(5): e10801.
58. Wang, T.J., Pencina, M.J., Booth, S.L. et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4): 503-11.
59. Trivedi, D.P., Doll, R., Khaw, K.T. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326(7387): 469.
60. Hsia, J., Heiss, G., Ren, H. et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115(7): 846-54.
61. Dawson-Hughes, B., Heaney, R.P., Holick, M.F., Lips, P., Meunier, P.J., Vieth, R. Estimates of optimal vitamin D status. Osteoporos Int 2005, 16(7): 713-6.
62. Sato, Y., Iwamoto, J., Kanoko, T., Satoh, K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 2005, 20(3): 187-92.
63. Sato, Y., Iwamoto, J., Kanoko, T., Satoh, K. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial. J Bone Miner Res 2005, 20(8): 1327-33.
64. Vasan, R.S. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006, 113(19): 2335-62.